CYP4A22 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-80496
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human CYP4A22. Peptide sequence AQLYLHRQWLLKALQQFPCPPSHWLFGHIQEFQHDQELQRIQERVKTFPS. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for CYP4A22 Antibody
![Western Blot: CYP4A22 Antibody [NBP1-80496]](https://resources.bio-techne.com/images/products/CYP4A22-Antibody-Western-Blot-NBP1-80496-img0002.jpg "Western Blot: CYP4A22 Antibody [NBP1-80496]")
Western Blot: CYP4A22 Antibody [NBP1-80496]
Western Blot: CYP4A22 Antibody [NBP1-80496] - Human Stomach, concentration 0.2-1 ug/ml.Applications for CYP4A22 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CYP4A22
Alternate Names
CYPIVA22, cytochrome P450 4A22K, cytochrome P450, family 4, subfamily A, polypeptide 22
Gene Symbol
CYP4A22
UniProt
Additional CYP4A22 Products
Product Documents for CYP4A22 Antibody
Product Specific Notices for CYP4A22 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...